3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gynecologic
1
Conditions
Ovarian Neoplasms
15
Uterine Cervical Neoplasms
9
Breast Neoplasms
7
Prostatic Neoplasms
4
Pancreatic Neoplasms
3
Fallopian Tube Neoplasms
3
Endometrial Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Ovarian Epithelial
3
Uterine Neoplasms
2
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Recurrence
2
Peritoneal Neoplasms
2
Papillomavirus Infections
2
Lung Neoplasms
2
Gynecologic Cancer
2
Esophageal Neoplasms
2
Vulvar Neoplasms
1
Skin Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Pseudomyxoma Peritonei
1
Neoplastic Syndromes, Hereditary
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Melanoma
1
Leukemia, Myeloid, Acute
1
Kenny-Caffey syndrome, Type 1
1
Interventions
Radiotherapy
3
Radiation
3
Paclitaxel
3
Cisplatin
3
Taxes
2
Carboplatin
2
Brachytherapy
2
Standard of Care
1
Practice Guidelines as Topic
1
Platinum
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Endometrial Clear Cell Adenocarcinoma
×
Standard of Care
×
Gynecologic
×
Clear all
NCT03422198
2025-12-12
SAVE
University of Utah
Phase 3
Recruiting
188 enrolled
15 charts